Reliance Nippon IPO sets price band, seeks to garner Rs1,542 crore

Reliance Nippon Life Asset Management Ltd (RNAM), comes up with an initial public offering (IPO), to raise up to Rs. 1,542 crore with the company, on Thursday.  The price band set of Rs. 247-252 per share. RNAM is a subsidiary of Reliance Capital, with Japan’s Nippon Life Insurance Co, as its strategic partner.

The offer will run from 25 to 27 October, involves a 10 percent stake sale in the company. Its two main shareholders viz. Nippon Life will sell up to 2.55 million and Anil Ambani’s Reliance Capital will sell up to 1.12 million shares, each.

JM Financial, Citic CLSA, Nomura and Axis Capital are the main banks managing the offer, while the book runners namely - Edelweiss, IIFL Holdings, SBI Capital Markets and Yes Securities.

Top Stocks for Tomorrow Trading By Technical Analyst ( 12 Sep 2017 )

Research Head (MONEY MAKER RESEARCH & INVESTMENT ADVISOR PVT LTD) is having a view that one can go long in PANACEA BIOTECH.

“PANACEA BIOTECH is looking bullish on Daily Charts & Bullish crossover in MACD and strong reading at ADX shows strong trend, therefore I recommend traders to go long around 266 with a price target of around 276 & Stop loss should be placed below 251”

The company has product portfolio that caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal. Panacea Biotec is the third largest biotechnology company (as per ABLE Survey, 2006), as well as among the top 50 pharmaceutical companies (as per ORG IMS July 2006) of India. The company has been granted patents across countries like USA, U.K., France, Germany, Italy, Sweden, Denmark, Spain, Finland, Switzerland, The Netherlands, New Zealand, Mexico, Brazil, Nigeria, Zimbabwe, Australia, South Africa, Japan, Russia, Canada, Ukraine, Korea and China are among others.

The company expanded its existing collaboration with Apotex Inc, the largest Canadian-owned pharmaceutical company, for sales & distribution of Prasugrel 5mg and 10mg tablets in the USA.

It has signed an exclusive license and supply agreement with Apotex for this purpose.

Stock has been gaining for the last 3 days and has risen 29.05% in the period